Hanns M. Lorenz

427 total citations
7 papers, 297 citations indexed

About

Hanns M. Lorenz is a scholar working on Radiology, Nuclear Medicine and Imaging, Surgery and Genetics. According to data from OpenAlex, Hanns M. Lorenz has authored 7 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Radiology, Nuclear Medicine and Imaging, 2 papers in Surgery and 2 papers in Genetics. Recurrent topics in Hanns M. Lorenz's work include Monoclonal and Polyclonal Antibodies Research (3 papers), Rheumatoid Arthritis Research and Therapies (2 papers) and Systemic Sclerosis and Related Diseases (2 papers). Hanns M. Lorenz is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), Rheumatoid Arthritis Research and Therapies (2 papers) and Systemic Sclerosis and Related Diseases (2 papers). Hanns M. Lorenz collaborates with scholars based in Germany, Japan and Switzerland. Hanns M. Lorenz's co-authors include Joachim R. Kalden, Steffen Gay, Renate E. Gay, Beat A. Michel, Jörg H. W. Distler, Marco Matucci‐Cerinic, Oliver Distler, Hans Peter, Ulf Müller‐Ladner and Joachim R. Kalden and has published in prestigious journals such as Journal of the American Society of Nephrology, Molecular Pharmacology and Lara D. Veeken.

In The Last Decade

Hanns M. Lorenz

7 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hanns M. Lorenz Germany	6	109	107	84	68	52	7	297
R.N. Poston United Kingdom	4	120 1.1×	47 0.4×	75 0.9×	22 0.3×	54 1.0×	7	362
Vincent Jachiet France	9	94 0.9×	62 0.6×	97 1.2×	83 1.2×	42 0.8×	22	325
Cindy Collins United States	6	158 1.4×	51 0.5×	101 1.2×	84 1.2×	108 2.1×	8	359
Stuart Weisman United States	5	136 1.2×	30 0.3×	110 1.3×	68 1.0×	31 0.6×	7	415
Wolfgang Merkt Germany	9	87 0.8×	108 1.0×	46 0.5×	21 0.3×	72 1.4×	20	278
Alicia Humbría Spain	8	183 1.7×	50 0.5×	136 1.6×	23 0.3×	56 1.1×	11	430
Francisco Díaz‐Crespo Spain	10	59 0.5×	126 1.2×	46 0.5×	23 0.3×	73 1.4×	37	268
Marie Godar Belgium	7	98 0.9×	42 0.4×	21 0.3×	58 0.9×	52 1.0×	7	306
Ulf M�ller-Ladner Germany	6	116 1.1×	39 0.4×	96 1.1×	119 1.8×	77 1.5×	8	322
K. Takehara Japan	7	75 0.7×	83 0.8×	151 1.8×	193 2.8×	40 0.8×	7	390

Countries citing papers authored by Hanns M. Lorenz

Since Specialization

Citations

This map shows the geographic impact of Hanns M. Lorenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanns M. Lorenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanns M. Lorenz more than expected).

Fields of papers citing papers by Hanns M. Lorenz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanns M. Lorenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanns M. Lorenz. The network helps show where Hanns M. Lorenz may publish in the future.

Co-authorship network of co-authors of Hanns M. Lorenz

This figure shows the co-authorship network connecting the top 25 collaborators of Hanns M. Lorenz. A scholar is included among the top collaborators of Hanns M. Lorenz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanns M. Lorenz. Hanns M. Lorenz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Röhrich, Manuel, Norbert Blank, Daniel Paech, et al.. (2024). Fibroblast activation protein inhibitor-positron emission tomography in aortitis: fibroblast pathology in active inflammation and remission. Lara D. Veeken. 63(9). 2473–2483. 11 indexed citations

2.

Nüßlein, H., Rieke Alten, Mauro Galeazzi, et al.. (2016). Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study.. PubMed. 34(3). 489–99. 29 indexed citations

3.

Distler, Jörg H. W., Astrid Jüngel, Otylia Kowal‐Bielecka, et al.. (2005). Expression of interleukin‐21 receptor in epidermis from patients with systemic sclerosis. Arthritis & Rheumatism. 52(3). 856–864. 115 indexed citations

4.

Distler, Jörg H. W., Ulf Müller‐Ladner, Hanns M. Lorenz, et al.. (2004). Bucillamine Induces the Synthesis of Vascular Endothelial Growth Factor Dose-Dependently in Systemic Sclerosis Fibroblasts via Nuclear Factor-κB and Simian Virus 40 Promoter Factor 1 Pathways. Molecular Pharmacology. 65(2). 389–399. 22 indexed citations

5.

Birck, Rainer, Klaus Warnatz, Hanns M. Lorenz, et al.. (2003). 15-Deoxyspergualin in Patients with Refractory ANCA-Associated Systemic Vasculitis. Journal of the American Society of Nephrology. 14(2). 440–447. 101 indexed citations

6.

Lorenz, Hanns M.. (2002). Technology evaluation: adalimumab, Abbott laboratories.. PubMed. 4(2). 185–90. 17 indexed citations

7.

Geiler, Thomas, Hanns M. Lorenz, Joachim R. Kalden, & Bernhard Manger. (1997). Pathogenese der rheumatoiden Arthritis. Medizinische Klinik. 92(6). 347–353. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact